9th Circ. Revives Whistleblower's FCA Row Against Merck
The Ninth Circuit on Thursday revived a whistleblower's allegations that Merck and two other drugmakers violated the False Claims Act by offering doctors kickbacks to prescribe their blood-thinning drugs, finding the...To view the full article, register now.
Already a subscriber? Click here to view full article